Cachet Pharmaceutical Co (SZSE:002462) 3-Year EBITDA Growth Rate : -7.60% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Cachet Pharmaceutical Co 3-Year EBITDA Growth Rate?

Cachet Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.66.

During the past 12 months, Cachet Pharmaceutical Co's average EBITDA Per Share Growth Rate was -11.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cachet Pharmaceutical Co was 69.90% per year. The lowest was -7.60% per year. And the median was 17.85% per year.

Competitive Comparison of Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Cachet Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cachet Pharmaceutical Co (SZSE:002462) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cachet Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cachet Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cachet Pharmaceutical Co (SZSE:002462) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cachet Pharmaceutical Co Ltd (SZSE:002462) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Building 1, No. 11 Kun Ming Hu South Road, Haidian District, Beijing, CHN, 100195

Website

http://www.cachet.com.cn

Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.

Executives

Xu Shuai	Director
Shen Fang	Executives
Bo Shi Jun	Executives
Feng Ze Ju	Executives
Xue Cui Ping	Executives
Wang Ying	Executives
Gao Ning	Supervisors
Wang Xin Xia	Directors, executives
Weng Xian Ding	Supervisors
Li Tie Jun	Executives

Cachet Pharmaceutical Co (SZSE:002462) Headlines

No Headlines